CytomX Therapeutics to Announce First Quarter 2017 Financial Results

Go back to CytomX Therapeutics to Announce First Quarter 2017 Financial Results
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.30 +0.01 (0.30%)
Previous Close $3.29    52 Week High $24.68 
Open $3.30    52 Week Low $9.10 
Day High $3.30    P/E N/A 
Day Low $3.30    EPS $0.00 
Volume 4,148